Method for prophylaxis of influenza using vaccine for intranasal administration
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Mar 28, 2017
Grant Date -
Apr 5, 2012
app pub date -
Mar 31, 2010
filing date -
Mar 31, 2009
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention provides a vaccine composition for transnasal mucous membrane administration, which contains an influenza virus antigen, polyriboinosinic polyribocytidylic acid (poly (I:C)) or a derivative thereof and a carboxyvinyl polymer. The present invention also provides a prophylactic method of influenza, including a step of administering the vaccine composition at least once to the nasal mucosa of a subject in need thereof.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully